| Identification | Back Directory | [Name]
(2’,3’,5’-Tri-O-acetyl)uridine 5-carboxylic acid | [CAS]
174653-39-5 | [Synonyms]
(2’,3’,5’-Tri-O-acetyl)uridine5-carboxylicacid
(2’,3’,5’-Tri-O-acetyl)uridine 5-carboxylic acid
5-Pyrimidinecarboxylic acid, 1,2,3,4-tetrahydro-2,4-dioxo-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)- | [Molecular Formula]
C16H18N2O11 | [MDL Number]
MFCD32215213 | [MOL File]
174653-39-5.mol | [Molecular Weight]
414.32 |
| Hazard Information | Back Directory | [Uses]
(2’,3’,5’-Tri-O-acetyl)uridine 5-carboxylic acid is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|